Literature DB >> 20431533

High-stringency tandem affinity purification of proteins conjugated to ubiquitin-like moieties.

Filip Golebiowski1, Michael H Tatham, Akihiro Nakamura, Ronald T Hay.   

Abstract

The post-translational modification of proteins with ubiquitin and ubiquitin-like proteins (Ubl) is vital to many cellular functions, and thus the identification of Ubl targets is key to understanding their function. In most cases, only a small proportion of the cellular pool of proteins is found conjugated to a particular Ubl, making identification of Ubl targets technically challenging. For the purposes of proteomic analyses, we have developed a protocol for the large-scale purification of Ubl-linked proteins that minimizes sample contamination with noncovalent interactors and prevents the cleavage of Ubl-substrate bonds catalyzed by Ubl-specific proteases. This is achieved by introducing a denaturing lysis step (in the presence of sodium dodecyl sulfate and alkylating agents that irreversibly inhibit Ubl proteases) before TAP (tandem affinity purification) that allows for efficient purification of putative Ubl-specific substrates in a form suitable for proteomic analysis. The timescale from cell lysis to purified protein sample is 5-6 d.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20431533     DOI: 10.1038/nprot.2010.40

Source DB:  PubMed          Journal:  Nat Protoc        ISSN: 1750-2799            Impact factor:   13.491


  46 in total

Review 1.  Ubiquitin and its kin: how close are the family ties?

Authors:  S Jentsch; G Pyrowolakis
Journal:  Trends Cell Biol       Date:  2000-08       Impact factor: 20.808

Review 2.  SUMO and transcriptional regulation.

Authors:  David W H Girdwood; Michael H Tatham; Ronald T Hay
Journal:  Semin Cell Dev Biol       Date:  2004-04       Impact factor: 7.727

Review 3.  Role of ubiquitin-like proteins in transcriptional regulation.

Authors:  R T Hay
Journal:  Ernst Schering Res Found Workshop       Date:  2006

4.  In-gel digestion for mass spectrometric characterization of proteins and proteomes.

Authors:  Andrej Shevchenko; Henrik Tomas; Jan Havlis; Jesper V Olsen; Matthias Mann
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 5.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

Review 6.  Principles of ubiquitin and SUMO modifications in DNA repair.

Authors:  Steven Bergink; Stefan Jentsch
Journal:  Nature       Date:  2009-03-26       Impact factor: 49.962

7.  Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.

Authors:  Helen J Cooper; Michael H Tatham; Ellis Jaffray; John K Heath; TuKiet T Lam; Alan G Marshall; Ronald T Hay
Journal:  Anal Chem       Date:  2005-10-01       Impact factor: 6.986

8.  Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation.

Authors:  Philipp Stelter; Helle D Ulrich
Journal:  Nature       Date:  2003-09-11       Impact factor: 49.962

Review 9.  Novel substrates and functions for the ubiquitin-like molecule NEDD8.

Authors:  Dimitris P Xirodimas
Journal:  Biochem Soc Trans       Date:  2008-10       Impact factor: 5.407

10.  A proteomic study of SUMO-2 target proteins.

Authors:  Alfred C O Vertegaal; Stephen C Ogg; Ellis Jaffray; Manuel S Rodriguez; Ronald T Hay; Jens S Andersen; Matthias Mann; Angus I Lamond
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

View more
  9 in total

1.  Unraveling the ubiquitome of the human malaria parasite.

Authors:  Nadia Ponts; Anita Saraf; Duk-Won D Chung; Alona Harris; Jacques Prudhomme; Michael P Washburn; Laurence Florens; Karine G Le Roch
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  The dynamics and mechanism of SUMO chain deconjugation by SUMO-specific proteases.

Authors:  Miklós Békés; John Prudden; Tharan Srikumar; Brian Raught; Michael N Boddy; Guy S Salvesen
Journal:  J Biol Chem       Date:  2011-01-19       Impact factor: 5.157

3.  Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies.

Authors:  Sina V Barysch; Claudia Dittner; Annette Flotho; Janina Becker; Frauke Melchior
Journal:  Nat Protoc       Date:  2014-03-20       Impact factor: 13.491

4.  The Human Cytomegalovirus IE1 Protein Antagonizes PML Nuclear Body-Mediated Intrinsic Immunity via the Inhibition of PML De Novo SUMOylation.

Authors:  Eva-Maria Schilling; Myriam Scherer; Nina Reuter; Johannes Schweininger; Yves A Muller; Thomas Stamminger
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 5.  The ubiquitin system: an essential component to unlocking the secrets of malaria parasite biology.

Authors:  Michael J Hamilton; Michael Lee; Karine G Le Roch
Journal:  Mol Biosyst       Date:  2014-01-30

6.  RSUME enhances glucocorticoid receptor SUMOylation and transcriptional activity.

Authors:  Jimena Druker; Ana C Liberman; María Antunica-Noguerol; Juan Gerez; Marcelo Paez-Pereda; Theo Rein; Jorge A Iñiguez-Lluhí; Florian Holsboer; Eduardo Arzt
Journal:  Mol Cell Biol       Date:  2013-03-18       Impact factor: 4.272

Review 7.  Proteomics strategies to identify SUMO targets and acceptor sites: a survey of RNA-binding proteins SUMOylation.

Authors:  Giuseppe Filosa; Silvia M L Barabino; Angela Bachi
Journal:  Neuromolecular Med       Date:  2013-08-25       Impact factor: 3.843

Review 8.  Uncovering ubiquitin and ubiquitin-like signaling networks.

Authors:  Alfred C O Vertegaal
Journal:  Chem Rev       Date:  2011-10-17       Impact factor: 60.622

9.  Global Reprogramming of Host SUMOylation during Influenza Virus Infection.

Authors:  Patricia Domingues; Filip Golebiowski; Michael H Tatham; Antonio M Lopes; Aislynn Taggart; Ronald T Hay; Benjamin G Hale
Journal:  Cell Rep       Date:  2015-11-05       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.